MLL-AF9 fusion protein overexpressed fetal liver (FL) cells and BMCs obtained from the Id1−/− mice are used to perform serial replanting assays to mimic infant and postnatal MLL-AF9-driven leukemia, respectively. This evidence concerns the gene ID1 and leukemia.